1,3-Diaryltriazenes: a new class of anorectic agents. 1983

D T Hill, and K G Stanley, and J E Williams, and B Loev, and P J Fowler, and J P McCafferty, and E Macko, and C E Berkoff, and C B Ladd

A series of substituted 1,3-diaryltriazenes has been synthesized and tested for anorectic activity. Several members of the series were effective; one compound, 1,3-bis[2-cyano-5-(trifluoromethyl)phenyl]triazene, was particularly active, causing weight loss in rats, dogs, and squirrel monkeys. It was devoid of overt central nervous system activity, and compared to previously reported biologically active triazenes, it was relatively nontoxic up to 30 days of drug administration.

UI MeSH Term Description Entries
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003913 Dextroamphetamine The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. d-Amphetamine,Curban,Dexamfetamine,Dexamphetamine,Dexedrine,Dextro-Amphetamine Sulfate,DextroStat,Dextroamphetamine Sulfate,Oxydess,d-Amphetamine Sulfate,dextro-Amphetamine,Dextro Amphetamine Sulfate,Sulfate, Dextroamphetamine,d Amphetamine,d Amphetamine Sulfate,dextro Amphetamine
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D005277 Fenfluramine A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release. Fintepla,Fenfluramine Hydrochloride,Fenfluramine Hydrochloride, (+-)-Isomer,Fenfluramine Hydrochloride, R-Isomer,Fenfluramine, (+-)-Isomer,Fenfluramine, R-Isomer,Isomeride,Pondimin,Fenfluramine Hydrochloride, R Isomer,Fenfluramine, R Isomer,Hydrochloride, Fenfluramine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001067 Appetite Depressants Agents that are used to suppress appetite. Anorectic,Anorectic Agent,Anorectics,Anorexic Drug,Anorexigenic Drug,Appetite Depressant,Appetite Suppressant,Appetite Suppressants,Appetite-Depressing Drug,Appetite-Suppressant Drug,Anorectic Agents,Anorexic Drugs,Anorexigenic Drugs,Appetite-Depressing Drugs,Appetite-Suppressant Drugs,Agent, Anorectic,Agents, Anorectic,Appetite Depressing Drug,Appetite Depressing Drugs,Appetite Suppressant Drug,Appetite Suppressant Drugs,Depressant, Appetite,Depressants, Appetite,Drug, Anorexic,Drug, Anorexigenic,Drug, Appetite-Depressing,Drug, Appetite-Suppressant,Drugs, Anorexic,Drugs, Anorexigenic,Drugs, Appetite-Depressing,Drugs, Appetite-Suppressant,Suppressant, Appetite,Suppressants, Appetite

Related Publications

D T Hill, and K G Stanley, and J E Williams, and B Loev, and P J Fowler, and J P McCafferty, and E Macko, and C E Berkoff, and C B Ladd
January 1992, The American journal of clinical nutrition,
D T Hill, and K G Stanley, and J E Williams, and B Loev, and P J Fowler, and J P McCafferty, and E Macko, and C E Berkoff, and C B Ladd
July 2011, European journal of medicinal chemistry,
D T Hill, and K G Stanley, and J E Williams, and B Loev, and P J Fowler, and J P McCafferty, and E Macko, and C E Berkoff, and C B Ladd
April 2014, European journal of medicinal chemistry,
D T Hill, and K G Stanley, and J E Williams, and B Loev, and P J Fowler, and J P McCafferty, and E Macko, and C E Berkoff, and C B Ladd
January 1976, Indian journal of experimental biology,
D T Hill, and K G Stanley, and J E Williams, and B Loev, and P J Fowler, and J P McCafferty, and E Macko, and C E Berkoff, and C B Ladd
April 2009, Bioorganic & medicinal chemistry letters,
D T Hill, and K G Stanley, and J E Williams, and B Loev, and P J Fowler, and J P McCafferty, and E Macko, and C E Berkoff, and C B Ladd
September 1970, Journal of medicinal chemistry,
D T Hill, and K G Stanley, and J E Williams, and B Loev, and P J Fowler, and J P McCafferty, and E Macko, and C E Berkoff, and C B Ladd
December 1982, Journal of medicinal chemistry,
D T Hill, and K G Stanley, and J E Williams, and B Loev, and P J Fowler, and J P McCafferty, and E Macko, and C E Berkoff, and C B Ladd
July 1977, Journal of medicinal chemistry,
D T Hill, and K G Stanley, and J E Williams, and B Loev, and P J Fowler, and J P McCafferty, and E Macko, and C E Berkoff, and C B Ladd
November 2001, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
D T Hill, and K G Stanley, and J E Williams, and B Loev, and P J Fowler, and J P McCafferty, and E Macko, and C E Berkoff, and C B Ladd
January 2006, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
Copied contents to your clipboard!